Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells

被引:326
作者
Muranen, Taru [1 ]
Selfors, Laura M. [1 ]
Worster, Devin T. [1 ]
Iwanicki, Marcin P. [1 ]
Song, Loling [1 ]
Morales, Fabiana C. [2 ]
Gao, Sizhen [1 ]
Mills, Gordon B. [2 ]
Brugge, Joan S. [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA
基金
芬兰科学院;
关键词
CAP-INDEPENDENT TRANSLATION; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; INSULIN-RECEPTOR; AKT ACTIVATION; UP-REGULATION; PI3K PATHWAY; BREAST; INITIATION; APOPTOSIS;
D O I
10.1016/j.ccr.2011.12.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The PI3K/mTOR-pathway is the most commonly dysregulated pathway in epithelial cancers and represents an important target for cancer therapeutics. Here, we show that dual inhibition of PI3K/mTOR in ovarian cancer-spheroids leads to death of inner matrix-deprived cells, whereas matrix-attached cells are resistant. This matrix-associated resistance is mediated by drug-induced upregulation of cellular survival programs that involve both FOXO-regulated transcription and cap-independent translation. Inhibition of any one of several upregulated proteins, including BcI-2, EGFR, or IGF1R, abrogates resistance to PI3K/mTOR inhibition. These results demonstrate that acute adaptive responses to PI3K/mTOR inhibition in matrix-attached cells resemble well-conserved stress responses to nutrient and growth factor deprivation. Bypass of this resistance mechanism through rational design of drug combinations could significantly enhance PI3K-targeted drug efficacy.
引用
收藏
页码:227 / 239
页数:13
相关论文
共 78 条
[1]   ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo [J].
Ackler, Scott ;
Xiao, Yu ;
Mitten, Michael J. ;
Foster, Kelly ;
Oleksijew, Anatol ;
Refici, Marion ;
Schlessinger, Sally ;
Wang, Baole ;
Chemburkar, Sanjay R. ;
Bauch, Joy ;
Tse, Christin ;
Frost, David J. ;
Fesik, Stephen W. ;
Rosenberg, Saul H. ;
Elmore, Steven W. ;
Shoemaker, Alex R. .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (10) :3265-3274
[2]   Initiation Factor eIF2-independent Mode of c-Src mRNA Translation Occurs via an Internal Ribosome Entry Site [J].
Allam, Heba ;
Ali, Naushad .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (08) :5713-5725
[3]   Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer [J].
Baselga, Jose .
ONCOLOGIST, 2011, 16 :12-19
[4]   A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer [J].
Braunstein, Steve ;
Karpisheva, Ksenia ;
Pola, Carolina ;
Goldberg, Judith ;
Hochman, Tsivia ;
Yee, Herman ;
Cangiarella, Joan ;
Arju, Rezina ;
Formenti, Silvia C. ;
Schneider, Robert J. .
MOLECULAR CELL, 2007, 28 (03) :501-512
[5]   Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor [J].
Brunet, A ;
Bonni, A ;
Zigmond, MJ ;
Lin, MZ ;
Juo, P ;
Hu, LS ;
Anderson, MJ ;
Arden, KC ;
Blenis, J ;
Greenberg, ME .
CELL, 1999, 96 (06) :857-868
[6]   A transforming mutation in the pleckstrin homology domain of AKT1 in cancer [J].
Carpten, John D. ;
Faber, Andrew L. ;
Horn, Candice ;
Donoho, Gregory P. ;
Briggs, Stephen L. ;
Robbins, Christiane M. ;
Hostetter, Galen ;
Boguslawski, Sophie ;
Moses, Tracy Y. ;
Savage, Stephanie ;
Uhlik, Mark ;
Lin, Aimin ;
Du, Jian ;
Qian, Yue-Wei ;
Zeckner, Douglas J. ;
Tucker-Kellogg, Greg ;
Touchman, Jeffrey ;
Patel, Ketan ;
Mousses, Spyro ;
Bittner, Michael ;
Schevitz, Richard ;
Lai, Mei-Huei T. ;
Blanchard, Kerry L. ;
Thomas, James E. .
NATURE, 2007, 448 (7152) :439-U1
[7]  
Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/JCI34739, 10.1172/jCI34739]
[8]   AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity [J].
Chandarlapaty, Sarat ;
Sawai, Ayana ;
Scaltriti, Maurizio ;
Rodrik-Outmezguine, Vanessa ;
Grbovic-Huezo, Olivera ;
Serra, Violeta ;
Majumder, Pradip K. ;
Baselga, Jose ;
Rosen, Neal .
CANCER CELL, 2011, 19 (01) :58-71
[9]   Anoikis: A necessary death program for anchorage-dependent cells [J].
Chiarugi, Paola ;
Giannoni, Elisa .
BIOCHEMICAL PHARMACOLOGY, 2008, 76 (11) :1352-1364
[10]   Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation [J].
Choo, Andrew Y. ;
Yoon, Sang-Oh ;
Kim, Sang Gyun ;
Roux, Philippe P. ;
Blenis, John .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (45) :17414-17419